Vaccines in the Golden Years
Journal of Infectious Diseases · Published 2026-07-21 · DOI 10.1093/infdis/jiag382
Authors (1)
H Keipp Talbot
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Talbot, H. (2026). Vaccines in the Golden Years. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag382
Related articles
- Effectiveness of Influenza Vaccines in Italy in the 2024/2025 Season: A Nationwide, Test‐Negative Design Study Based on Surveillance Records · Influenza and Other Respiratory Viruses · 2026 · Cites or is cited by this article
- Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness — United States, September 2025–February 2026 · Morbidity and Mortality Weekly Report · 2026 · Cites or is cited by this article
- Comparative Evaluation of E6/E7 mRNA Expression and Viral DNA Load in Cervical Lesions With Multiple High-Risk Human Papillomavirus Infection · Journal of Infectious Diseases · 2026 · Same journal
- Diverse Genetic Lineages Spreading Across Healthcare and Community Boundaries Underlie Extended-Spectrum Cephalosporin-Resistant Enterobacterales Colonization Burden in Botswana · Journal of Infectious Diseases · 2026 · Same journal
- Repeated Influenza Vaccination in Children: Effect Scale, Timing, and Causal Interpretation · Journal of Infectious Diseases · 2026 · Same journal
- Influenza Attack Rates and Vaccine Effectiveness by Prior-Season Infection and Vaccination: A 17-Season Analysis · Journal of Infectious Diseases · 2026 · Same journal
- Characterization of hepatitis B virus in blood donors who were disqualified based on testing: genotype distribution, infectivity, and replicative fitness in human hepatocytes · Journal of Infectious Diseases · 2026 · Same journal
- Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 RSV Vaccine Administered 24 Months Following a Primary Dose in Adults ≥60 Years of Age · Journal of Infectious Diseases · 2026 · Same journal
- Shortening HCV Treatment in US Jails: Opportunities and Implementation Considerations · Journal of Infectious Diseases · 2026 · Same journal
- Neutralization Capacity Against SARS-CoV-2 Ancestral, Delta, and Omicron Variants Before and After Heterologous Booster Vaccination in Fijian Healthcare Workers · Journal of Infectious Diseases · 2026 · Same journal